Loading company…
SHANMU develops AI-powered home health monitoring products, including a real-time urinalysis device.
Founded in 2020, SHANMU is based in Shenzhen, China. Its S1 home health robot analyzes more than 10 urine metabolism indicators, with results and guidance available through the SHANMU app. The company has applied for 53 patents, and its perception products have completed controlled clinical trials at several hospitals. In May 2026, it raised approximately CNY 100 million in Series A funding led by Stony Creek Capital, with participation from AfterShokz, Bojiang Capital Management Group, Yonghua Capital, Shanghai Angel Group, Zhixing Research Institute and Wanwuwei Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in